Interactions of antimitotic peptides and depsipeptides with tubulin

被引:38
作者
Hamel, E [1 ]
机构
[1] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA
关键词
tubulin; antimitotic peptides; depsipeptides; microtubules; spindle formation; catharanthus alkaloid binding; GTP hydrolysis; nucleotide turnover;
D O I
10.1002/bip.10255
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tubulin is the target for an ever increasing number of structurally unusual peptides and depsipeptides isolated from a wide range of organisms. Since tubulin is the subunit protein of microtubules, the compounds are usually potently toxic to mammalian cells. Without exception, these (depsi)peptides disrupt cellular microtubules and prevent spindle formation. This causes cells to accumulate at the G2/M phase of the cell cycle through inhibition of mitosis. In biochemical assays, the compounds inhibit microtubule assembly from tubulin and suppress microtubule dynamics at low concentrations. Most of the (depsi)peptides inhibit the binding of Catharanthus alkaloids to tubulin in a noncompetitive manner, GTP hydrolysis by tubulin, and nucleotide turnover at the exchangeable GTP site on beta-tubulin. In general, the (depsi)peptides induce the formation of tubulin oligomers of aberrant morphology. In all cases tubulin rings appear to be formed, but these rings differ in diameter, depending on the (depsi)peptide present during their formation. (C) 2002 Wiley Periodicals, Inc.*.
引用
收藏
页码:142 / 160
页数:19
相关论文
共 172 条
  • [1] Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay
    Aherne, GW
    Hardcastle, A
    Valenti, M
    Bryant, A
    Rogers, P
    Pettit, GR
    Srirangam, JK
    Kelland, LR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (03) : 225 - 232
  • [2] Ali MA, 1998, ANTICANCER RES, V18, P1021
  • [3] Total synthesis of (-)-hemiasterlin, a structurally novel tripeptide that exhibits potent cytotoxic activity
    Andersen, RJ
    Coleman, JE
    Piers, E
    Wallace, DJ
    [J]. TETRAHEDRON LETTERS, 1997, 38 (03) : 317 - 320
  • [4] Anderson HJ, 1997, CANCER CHEMOTH PHARM, V39, P223
  • [5] BAI R, 1991, J BIOL CHEM, V266, P15882
  • [6] BAI R, 1990, J BIOL CHEM, V265, P17141
  • [7] DOLASTATIN-10, A POWERFUL CYTOSTATIC PEPTIDE DERIVED FROM A MARINE ANIMAL - INHIBITION OF TUBULIN POLYMERIZATION MEDIATED THROUGH THE VINCA ALKALOID BINDING DOMAIN
    BAI, R
    PETTIT, GR
    HAMEL, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) : 1941 - 1949
  • [8] DOLASTATIN-15, A POTENT ANTIMITOTIC DEPSIPEPTIDE DERIVED FROM DOLABELLA-AURICULARIA - INTERACTION WITH TUBULIN AND EFFECTS ON CELLULAR MICROTUBULES
    BAI, R
    FRIEDMAN, SJ
    PETTIT, GR
    HAMEL, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) : 2637 - 2645
  • [9] Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: Comparison with dolastatin 10 and cryptophycin 1
    Bai, RL
    Durso, NA
    Sackett, DL
    Hamel, E
    [J]. BIOCHEMISTRY, 1999, 38 (43) : 14302 - 14310
  • [10] Direct photoaffinity labeling of cysteine-295 of α-tubulin by guanosine 5′-triphosphate bound in the nonexchangeable site
    Bai, RL
    Choe, K
    Ewell, JB
    Nguyen, NY
    Hamel, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) : 9894 - 9897